Loading…
S. 3452119th CongressIn committeeLatest action Dec 11, 2025Decoded by AI · checked against the record
Official title: Biological Intellectual Property Protection Act of 2025
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
S 3452 would require US companies and researchers to get a Commerce license before sending synthetic DNA/RNA files to China, Russia, Iran, or North Korea.
50-second read · 4 questions answered below
S 3452 would require American companies and researchers to obtain a government export license before sharing digital files of synthetic DNA or RNA sequences with entities in countries designated as national security threats. The Department of Commerce would have one year to build and launch the licensing system. Information already considered publicly available would be exempt from the requirement.
US biotechnology companies, university research labs, and scientists who share or sell synthetic biology data with partners in flagged countries would need to apply for licenses before sending that information. Foreign companies and research institutions in countries of concern would face restricted access to US-designed genetic sequence files.
Congress has expressed concern that custom DNA and RNA sequence designs sent to countries like China could reach foreign military or intelligence services. Organizations currently sharing synthetic biology data internationally would face a new approval process that did not previously exist for these digital files.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.